By: Nicolas R., Charles F., Morris, Charles D., Chen, Andrew J., Brian A., Jacob W.,, Randall J., Ossenkoppele, David M., Erik, Suzanne E., John C., Holtzman
Salvadó et al. developed and validated a CSF-based staging model for sporadic Alzheimer’s disease, which accurately reflects biomarker and clinical changes, enhancing diagnostic and prognostic assessments of participants for clinical setting and trials.